Takaji Wakita
#135,262
Most Influential Person Now
Medical scientist in Japan
Takaji Wakita's AcademicInfluence.com Rankings
Takaji Wakitabiology Degrees
Biology
#9218
World Rank
#12395
Historical Rank
Virology
#211
World Rank
#218
Historical Rank
Immunology
#547
World Rank
#565
Historical Rank

Download Badge
Biology
Takaji Wakita's Degrees
- PhD Medical Science University of Tokyo
- Doctorate Medicine University of Tokyo
Why Is Takaji Wakita Influential?
(Suggest an Edit or Addition)Takaji Wakita's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (2005) (2882)
- Robust hepatitis C virus infection in vitro. (2005) (1828)
- The lipid droplet is an important organelle for hepatitis C virus production (2007) (1211)
- Detection of hepatitis C virus by polymerase chain reaction and response to interferon‐α therapy: Relationship to genotypes of hepatitis C virus (1992) (656)
- Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. (2003) (634)
- Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis (2006) (615)
- Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells (2006) (384)
- Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71 (2009) (376)
- Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles (2008) (370)
- The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. (2015) (353)
- Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response (2008) (336)
- Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19) (2020) (292)
- Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81 (2007) (280)
- Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient * (2001) (269)
- Apolipoprotein B–dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin (2008) (258)
- Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. (2014) (253)
- Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. (1996) (251)
- DDX3 DEAD-Box RNA Helicase Is Required for Hepatitis C Virus RNA Replication (2007) (250)
- Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP) (2014) (214)
- Subcellular Localization of Hepatitis C Virus Structural Proteins in a Cell Culture System That Efficiently Replicates the Virus (2006) (209)
- Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection (2008) (193)
- Cell culture and infection system for hepatitis C virus (2006) (186)
- Knockdown of autophagy-related gene decreases the production of infectious Hepatitis C virus particles (2009) (175)
- Robust Production of Infectious Hepatitis C Virus (HCV) from Stably HCV cDNA-Transfected Human Hepatoma Cells (2005) (173)
- Molecular biology of hepatitis C virus (2007) (172)
- Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. (2010) (165)
- Noroviruses Distinguish between Type 1 and Type 2 Histo-Blood Group Antigens for Binding (2008) (162)
- A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans (2013) (161)
- Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication (2006) (154)
- Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. (1992) (153)
- Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. (2007) (153)
- Hepatitis C viral life cycle. (2007) (151)
- Hepatitis C Virus Nonstructural 4B Protein Modulates Sterol Regulatory Element-binding Protein Signaling via the AKT Pathway* (2009) (142)
- Structure of Hepatitis E Virion-sized Particle Reveals an RNA-dependent Viral Assembly Pathway* (2010) (141)
- Nonhepatic Cell Lines HeLa and 293 Support Efficient Replication of the Hepatitis C Virus Genotype 2a Subgenomic Replicon (2005) (140)
- Phosphatidylinositol 4-Kinase III Beta Is a Target of Enviroxime-Like Compounds for Antipoliovirus Activity (2010) (137)
- An Attenuated Strain of Enterovirus 71 Belonging to Genotype A Showed a Broad Spectrum of Antigenicity with Attenuated Neurovirulence in Cynomolgus Monkeys (2007) (135)
- CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection (2007) (133)
- Infectivity of Hepatitis C Virus Is Influenced by Association with Apolipoprotein E Isoforms (2010) (132)
- Nuclear Localization of Japanese Encephalitis Virus Core Protein Enhances Viral Replication (2005) (132)
- Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization (2019) (131)
- Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. (2010) (130)
- Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. (1993) (129)
- A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. (1993) (128)
- miR-122 Stimulates Hepatitis C Virus RNA Synthesis by Altering the Balance of Viral RNAs Engaged in Replication versus Translation (2015) (126)
- Genotype 2a Hepatitis C Virus Subgenomic Replicon Can Replicate in HepG2 and IMY-N9 Cells* (2004) (126)
- Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus Infection (2007) (125)
- Hepatitis C Virus Reveals a Novel Early Control in Acute Immune Response (2011) (119)
- Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship — Yokohama, Japan, February 2020 (2020) (118)
- Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. (2018) (117)
- Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures (2007) (116)
- Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence. (1994) (116)
- Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)* (2013) (114)
- E6AP Ubiquitin Ligase Mediates Ubiquitylation and Degradation of Hepatitis C Virus Core Protein (2006) (113)
- NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry (2014) (113)
- Hepatitis C Virus Controls Interferon Production through PKR Activation (2010) (113)
- Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan (2021) (112)
- Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells (2018) (112)
- Efficient Conditional Transgene Expression in Hepatitis C Virus cDNA Transgenic Mice Mediated by the Cre/loxP System* (1998) (111)
- Antiviral Lectins from Red and Blue-Green Algae Show Potent In Vitro and In Vivo Activity against Hepatitis C Virus (2012) (108)
- Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro (2013) (107)
- Cooperative Effect of the Attenuation Determinants Derived from Poliovirus Sabin 1 Strain Is Essential for Attenuation of Enterovirus 71 in the NOD/SCID Mouse Infection Model (2007) (106)
- Replication of a hepatitis C virus replicon clone in mouse cells (2006) (104)
- Generation of Infectious Hepatitis C Virus in Immortalized Human Hepatocytes (2006) (101)
- Oxysterol-Binding Protein Family I Is the Target of Minor Enviroxime-Like Compounds (2013) (98)
- Enterovirus 71 Binding to PSGL-1 on Leukocytes: VP1-145 Acts as a Molecular Switch to Control Receptor Interaction (2013) (96)
- Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein (2010) (96)
- Expression and immune response to hepatitis C virus core DNA–based vaccine constructs (1996) (95)
- Visualization and Measurement of ATP Levels in Living Cells Replicating Hepatitis C Virus Genome RNA (2012) (94)
- Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers. (1991) (94)
- Hepatitis virus infection affects DNA methylation in mice with humanized livers. (2014) (94)
- Detection of Anti-Hepatitis C Virus Effects of Interferon and Ribavirin by a Sensitive Replicon System (2005) (92)
- Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity (2016) (91)
- Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. (2008) (91)
- Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment (2021) (90)
- The ESCRT System Is Required for Hepatitis C Virus Production (2011) (88)
- Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants (2021) (88)
- Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M (2017) (87)
- Regulation of Hepatitis C Virus Replication by Interferon Regulatory Factor 1 (2004) (87)
- Role of the Endoplasmic Reticulum-associated Degradation (ERAD) Pathway in Degradation of Hepatitis C Virus Envelope Proteins and Production of Virus Particles* (2011) (85)
- Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone. (2005) (85)
- The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles (2007) (84)
- Involvement of Hepatitis C Virus NS5A Hyperphosphorylation Mediated by Casein Kinase I-α in Infectious Virus Production (2014) (83)
- Human sapovirus classification based on complete capsid nucleotide sequences (2012) (83)
- 25‐hydroxyvitamin D3 suppresses hepatitis C virus production (2012) (83)
- Hepatitis C virus–infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells (2008) (82)
- Apoptosis in cultured rat hepatocytes: The effects of tumour necrosis factor α and interferon γ (1991) (81)
- Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line. (2014) (78)
- Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized mice. (2015) (78)
- Tyrosine Sulfation of the Amino Terminus of PSGL-1 Is Critical for Enterovirus 71 Infection (2010) (77)
- The DNA Damage Sensors Ataxia-Telangiectasia Mutated Kinase and Checkpoint Kinase 2 Are Required for Hepatitis C Virus RNA Replication (2008) (74)
- Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus (2018) (74)
- Regulation of CXCL-8 (Interleukin-8) Induction by Double-Stranded RNA Signaling Pathways during Hepatitis C Virus Infection (2006) (74)
- Surveillance of pathogens in outpatients with gastroenteritis and characterization of sapovirus strains between 2002 and 2007 in Kumamoto Prefecture, Japan (2009) (73)
- Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice. (2013) (71)
- Amphipathic α-Helices in Apolipoproteins Are Crucial to the Formation of Infectious Hepatitis C Virus Particles (2014) (71)
- Characterization of self-assembled virus-like particles of rat hepatitis E virus generated by recombinant baculoviruses (2011) (71)
- Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development. (2019) (69)
- Sphingomyelin Activates Hepatitis C Virus RNA Polymerase in a Genotype-Specific Manner (2010) (66)
- A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide (2015) (65)
- Hepatitis C virus JFH‐1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation (2008) (64)
- Multidrug treatment with nelfinavir and cepharanthine against COVID-19 (2020) (64)
- Rapid and real-time detection of hepatitis A virus by reverse transcription loop-mediated isothermal amplification assay. (2007) (64)
- The NS3 Helicase and NS5B-to-3′X Regions Are Important for Efficient Hepatitis C Virus Strain JFH-1 Replication in Huh7 Cells (2007) (63)
- Proteasomal Turnover of Hepatitis C Virus Core Protein Is Regulated by Two Distinct Mechanisms: a Ubiquitin-Dependent Mechanism and a Ubiquitin-Independent but PA28γ-Dependent Mechanism (2008) (63)
- High prevalence of rat hepatitis E virus in wild rats in China. (2013) (61)
- Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus (2016) (61)
- Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak (2020) (61)
- Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon (2007) (59)
- Hepatitis B core antigen-specific IFN-gamma production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. (1989) (59)
- Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death. (2008) (59)
- Development of a Rapid High-Throughput Method for High-Resolution Melting Analysis for Routine Detection and Genotyping of Noroviruses (2008) (58)
- Structural Basis for the Recognition of Lewis Antigens by Genogroup I Norovirus (2012) (58)
- Chaperonin TRiC/CCT participates in replication of hepatitis C virus genome via interaction with the viral NS5B protein. (2011) (57)
- Replication of hepatitis C virus genotype 3a in cultured cells. (2013) (57)
- A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins (2017) (57)
- Characterization of three novel monoclonal antibodies against hepatitis C virus core protein (1996) (57)
- Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship (2020) (57)
- Valosin-Containing Protein (VCP/p97) Is Required for Poliovirus Replication and Is Involved in Cellular Protein Secretion Pathway in Poliovirus Infection (2012) (57)
- RNA Polymerase Activity and Specific RNA Structure Are Required for Efficient HCV Replication in Cultured Cells (2010) (56)
- The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model (2015) (56)
- Serum interleukin 6 levels in patients with chronic hepatitis B. (1991) (55)
- Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection (1995) (54)
- Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C. (2011) (53)
- Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs. (1998) (53)
- Hepatitis C Virus Infection Sensitizes Human Hepatocytes to TRAIL-Induced Apoptosis in a Caspase 9-Dependent Manner1 (2008) (53)
- Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Expression* (2014) (52)
- 2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro. (2010) (51)
- Comparison between Subgenomic Replicons of Hepatitis C Virus Genotypes 2a (JFH-1) and 1b (Con1 NK5.1) (2005) (51)
- Ethanol Enhances Hepatitis C Virus Replication through Lipid Metabolism and Elevated NADH/NAD+* (2009) (51)
- Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime. (2009) (51)
- Identification of annexin A1 as a novel substrate for E6AP‐mediated ubiquitylation (2009) (49)
- Rab18 is required for viral assembly of hepatitis C virus through trafficking of the core protein to lipid droplets. (2014) (49)
- Development of hepatitis C virus genotype 3a cell culture system (2014) (48)
- Monoclonal Antibodies against Extracellular Domains of Claudin-1 Block Hepatitis C Virus Infection in a Mouse Model (2015) (47)
- Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system. (2011) (47)
- Hepatitis E Virus Outbreak in Monkey Facility, Japan (2012) (47)
- Genetic Variation of the IL-28B Promoter Affecting Gene Expression (2011) (47)
- Susceptibility of laboratory rats against genotypes 1, 3, 4, and rat hepatitis E viruses. (2013) (46)
- A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection. (2010) (46)
- Production of infectious dromedary camel hepatitis E virus by a reverse genetic system: Potential for zoonotic infection. (2016) (46)
- Novel Cell Culture-Adapted Genotype 2a Hepatitis C Virus Infectious Clone (2012) (46)
- Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle. (2013) (46)
- Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6. (2009) (46)
- Genotype 5 Hepatitis E Virus Produced by a Reverse Genetics System Has the Potential for Zoonotic Infection (2018) (45)
- Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease. (1990) (45)
- Primary hepatocyte culture supports hepatitis C virus replication: A model for infection‐associated hepatocarcinogenesis (2010) (44)
- De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry. (2018) (44)
- Signal Peptidase Complex Subunit 1 Participates in the Assembly of Hepatitis C Virus through an Interaction with E2 and NS2 (2013) (44)
- Production of Infectious Hepatitis C Virus by Using RNA Polymerase I-Mediated Transcription (2010) (44)
- Efficient replication systems for hepatitis C virus using a new human hepatoma cell line. (2009) (44)
- Involvement of Creatine Kinase B in Hepatitis C Virus Genome Replication through Interaction with the Viral NS4A Protein (2009) (44)
- Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4. (2011) (44)
- Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response. (2007) (43)
- Norovirus Binding to Intestinal Epithelial Cells Is Independent of Histo-Blood Group Antigens (2013) (43)
- Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection (2017) (42)
- Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication. (2010) (42)
- Asian Musk Shrew as a Reservoir of Rat Hepatitis E Virus, China (2013) (42)
- Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide (2015) (42)
- Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1 (2011) (42)
- Tightly regulated expression of the entire hepatitis C virus structural region in continuous human cell lines. (1998) (40)
- Japanese Reference Panel of Blood Specimens for Evaluation of Hepatitis C Virus RNA and Core Antigen Quantitative Assays (2012) (40)
- Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus (2016) (40)
- The Hepatitis E Virus Capsid C-Terminal Region Is Essential for the Viral Life Cycle: Implication for Viral Genome Encapsidation and Particle Stabilization (2013) (39)
- Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection (2017) (39)
- Inoculation of Plasmids Encoding Japanese Encephalitis Virus PrM-E Proteins with Colloidal Gold Elicits a Protective Immune Response in BALB/c Mice (2003) (39)
- Monitoring the Antiviral Effect of Alpha Interferon on Individual Cells (2007) (38)
- Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection (2015) (38)
- Antimicrobial peptide LL‐37 attenuates infection of hepatitis C virus (2016) (38)
- Effects of TJ-9 Sho-saiko-to (kampo medicine) on interferon gamma and antibody production specific for hepatitis B virus antigen in patients with type B chronic hepatitis. (1991) (38)
- Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice. (2008) (37)
- Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism. (2015) (37)
- A Genome Epidemiological Study of SARS-CoV-2 Introduction into Japan (2020) (37)
- The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network (2019) (37)
- Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA transgenic mice mediated by Cre/loxP system (2000) (37)
- Binding activity of norovirus and sapovirus to histo-blood group antigens (2006) (36)
- Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice. (2009) (36)
- Descriptive study of COVID-19 outbreak among passengers and crew on Diamond Princess cruise ship, Yokohama Port, Japan, 20 January to 9 February 2020 (2020) (36)
- Corrigendum: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (2005) (35)
- Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus (2008) (35)
- A Disulfide-Bonded Dimer of the Core Protein of Hepatitis C Virus Is Important for Virus-Like Particle Production (2010) (35)
- HCV NS3 protease enhances liver fibrosis via binding to and activating TGF-β type I receptor (2013) (35)
- Comparison between cytomegalovirus promoter and elongation factor-1 alpha promoter-driven constructs in the establishment of cell lines expressing hepatitis C virus core protein. (1997) (35)
- Processing of hepatitis C virus core protein is regulated by its C‐terminal sequence (2003) (35)
- Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication (2017) (35)
- Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2 (2017) (34)
- Induction of humoural and cellular immunity by immunisation with HCV particle vaccine in a non-human primate model (2016) (34)
- Characterization of sapoviruses detected in gastroenteritis outbreaks and identification of asymptomatic adults with high viral load. (2009) (34)
- High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon (2018) (34)
- Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients (1997) (34)
- Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes (2019) (33)
- Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice (2003) (33)
- Arsenic Trioxide Inhibits Hepatitis C Virus RNA Replication through Modulation of the Glutathione Redox System and Oxidative Stress (2008) (33)
- Prominent Steatosis with Hypermetabolism of the Cell Line Permissive for Years of Infection with Hepatitis C Virus (2014) (33)
- A confirmation of sapovirus re-infection gastroenteritis cases with different genogroups and genetic shifts in the evolving sapovirus genotypes, 2002-2011 (2012) (33)
- Isolation of JFH-1 strain and development of an HCV infection system. (2009) (32)
- Inhibitory Effects of Caffeic Acid, a Coffee-Related Organic Acid, on the Propagation of Hepatitis C Virus. (2015) (32)
- Induction of hepatic injury by hepatitis C virus-specific CD8+ murine cytotoxic T lymphocytes in transgenic mice expressing the viral structural genes. (2003) (32)
- Chronic Hepatitis B Prevalence among Children and Mothers: Results from a Nationwide, Population-Based Survey in Lao People's Democratic Republic (2014) (32)
- Development of a Poliovirus Neutralization Test with Poliovirus Pseudovirus for Measurement of Neutralizing Antibody Titer in Human Serum (2011) (32)
- Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of mutants with enhanced cytopathogenicity and replication capacity. (2008) (32)
- Inactivation of hepatitis A virus by heat and high hydrostatic pressure: variation among laboratory strains (2009) (31)
- Production of single-round infectious chimeric flaviviruses with DNA-based Japanese encephalitis virus replicon. (2014) (31)
- Report from a Viral Hepatitis Policy Forum on implementing the WHO Framework for Global Action on viral hepatitis in North Asia. (2013) (31)
- Apoptosis in cultured rat hepatocytes: the effects of tumour necrosis factor alpha and interferon gamma. (1991) (31)
- Pilot study of ribavirin and interferon‐β for chronic hepatitis B (1993) (31)
- Quantitative analysis of fecal sapovirus shedding: identification of nucleotide substitutions in the capsid protein during prolonged excretion (2009) (30)
- A national reference for inactivated polio vaccine derived from Sabin strains in Japan. (2014) (30)
- Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction (2018) (30)
- Treatment with human gamma interferon of chronic hepatitis B: Comparative study with alpha interferon (1991) (30)
- Cellular vimentin content regulates the protein level of hepatitis C virus core protein and the hepatitis C virus production in cultured cells. (2009) (30)
- Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy (2015) (30)
- Characterization of miR-122-independent propagation of HCV (2017) (29)
- Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020 (2020) (29)
- TT virus infection in hemodialysis patients (1999) (29)
- Isolation and characterization of an Huh.7.5.1-derived cell clone highly permissive to hepatitis C virus. (2015) (29)
- A cell-based, microplate colorimetric screen identifies 7,8-benzoflavone and green tea gallate catechins as inhibitors of the hepatitis C virus. (2012) (29)
- The aryl hydrocarbon receptor–cytochrome P450 1A1 pathway controls lipid accumulation and enhances the permissiveness for hepatitis C virus assembly (2018) (28)
- Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins. (2008) (28)
- Griseofulvin, an oral antifungal agent, suppresses hepatitis C virus replication in vitro (2008) (28)
- Toll-Like Receptor 2 Senses Hepatitis C Virus Core Protein but Not Infectious Viral Particles (2009) (28)
- Comparison of envelope and precore/core variants of hepatitis B virus (HBV) during chronic HBV infection. (1993) (28)
- Ferret hepatitis E virus infection induces acute hepatitis and persistent infection in ferrets. (2016) (28)
- Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression (1999) (27)
- Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha (2010) (27)
- Environmental sampling for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during a coronavirus disease (COVID-19) outbreak aboard a commercial cruise ship (2020) (27)
- Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway (2010) (26)
- Complete Genome Sequence of a Novel GV.2 Sapovirus Strain, NGY-1, Detected from a Suspected Foodborne Gastroenteritis Outbreak (2015) (26)
- Development of a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) system for a highly sensitive detection of enterovirus in the stool samples of acute flaccid paralysis cases (2009) (25)
- Production of tumor necrosis factor, interleukin 1, and interferon-gamma by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. (1990) (25)
- Involvement of the 3’ Untranslated Region in Encapsidation of the Hepatitis C Virus (2016) (25)
- Hepatitis A outbreak associated with a revolving sushi bar in Chiba, Japan: Application of molecular epidemiology (2012) (25)
- Targeting Cellular Squalene Synthase, an Enzyme Essential for Cholesterol Biosynthesis, Is a Potential Antiviral Strategy against Hepatitis C Virus (2014) (25)
- Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents (2016) (25)
- Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives. (2013) (24)
- Trans-complemented hepatitis C virus particles as a versatile tool for study of virus assembly and infection. (2012) (24)
- Scavenger Receptor BI Is a Key Host Factor for Hepatitis C Virus Infection Required for an Entry Step Closely Linked to CD 81 (2009) (24)
- New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: Prevalence in Italian blood donors and patients with chronic liver or kidney diseases. (2016) (24)
- An infectious and selectable full‐length replicon system with hepatitis C virus JFH‐1 strain (2007) (24)
- Cell culture and in vivo analyses of cytopathic hepatitis C virus mutants. (2010) (24)
- A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction. (2018) (23)
- Development of Mouse Hepatocyte Lines Permissive for Hepatitis C Virus (HCV) (2011) (23)
- Serial analysis of hepatitis B virus core nucleotide sequence of patients with acute exacerbation during chronic infection (1996) (23)
- Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA (2018) (23)
- Hepatitis B virus X protein impairs α‐interferon signaling via up‐regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A (2017) (23)
- Prevalence of SARS-CoV-2–Specific Antibodies, Japan, June 2020 (2021) (23)
- Characterization of porcine sapelovirus isolated from Japanese swine with PLC/PRF/5 cells (2018) (23)
- Structural requirements of virion-associated cholesterol for infectivity, buoyant density and apolipoprotein association of hepatitis C virus. (2011) (23)
- Molecular characterization of sapovirus detected in a gastroenteritis outbreak at a wedding hall (2010) (23)
- In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosis (2011) (22)
- Hepatitis C Virus Nonstructural 5 A Protein Inhibits Lipopolysaccharide-Mediated Apoptosis of Hepatocytes by Decreasing Expression of Toll-Like Receptor 4 (2011) (22)
- RNA Exosome Complex Regulates Stability of the Hepatitis B Virus X-mRNA Transcript in a Non-stop-mediated (NSD) RNA Quality Control Mechanism* (2016) (22)
- Epidemiological and genetic analysis of a 2014 outbreak of hepatitis A in Japan. (2015) (22)
- E6AP ubiquitin ligase mediates ubiquitin‐dependent degradation of peroxiredoxin 1 (2010) (22)
- Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study (2021) (22)
- Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine proteases derived from patients with hepatic diseases (2009) (22)
- Epidemiological and genetic analyses of a diffuse outbreak of hepatitis A in Japan, 2010. (2012) (22)
- Replication and infectivity of a novel genotype 1b hepatitis C virus clone (2012) (21)
- Effects of various cytokines on collagen synthesis by normal rat hepatocytes in primary cultures and fibroblasts. (1989) (21)
- Suppression of La Antigen Exerts Potential Antiviral Effects against Hepatitis A Virus (2014) (21)
- CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c‐jun N terminal kinase activation independent from the interferon pathway (2013) (20)
- Identification of bisindolylmaleimides and indolocarbazoles as inhibitors of HCV replication by tube-capture-RT-PCR. (2009) (20)
- Production and characterization of HCV particles from serum-free culture. (2011) (20)
- Epidemiological and genetic analyses of a diffuse outbreak of hepatitis A in Japan, 2010. (2012) (20)
- Concept of Viral Inhibitors via NTCP (2019) (20)
- Evaluation of Heating Conditions for Inactivation of Hepatitis E Virus Genotypes 3 and 4. (2018) (20)
- Alternative endocytosis pathway for productive entry of hepatitis C virus. (2014) (20)
- Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model (2018) (20)
- Characterization of self-assembled virus-like particles of ferret hepatitis E virus generated by recombinant baculoviruses. (2013) (20)
- Involvement of PUF60 in Transcriptional and Post-transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression (2017) (19)
- Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation. (2012) (19)
- Virological characterization of the hepatitis C virus JFH-1 strain in lymphocytic cell lines. (2008) (19)
- An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes (2019) (19)
- Acidic polysaccharides isolated from marine algae inhibit the early step of viral infection. (2019) (19)
- Fatty acid biosynthesis is involved in the production of hepatitis B virus particles. (2016) (19)
- Immunization with a Recombinant Vaccinia Virus That Encodes Nonstructural Proteins of the Hepatitis C Virus Suppresses Viral Protein Levels in Mouse Liver (2012) (19)
- Epidemiology of domestically acquired hepatitis E virus infection in Japan: assessment of the nationally reported surveillance data, 2007-2013. (2015) (18)
- Characterization of self-assembled virus-like particles of dromedary camel hepatitis e virus generated by recombinant baculoviruses (2015) (18)
- Cyclophilin inhibitors reduce phosphorylation of RNA-dependent protein kinase to restore expression of IFN-stimulated genes in HCV-infected cells. (2014) (18)
- Candidatus Mycoplasma haemohominis in Human, Japan (2020) (18)
- Revisiting the guidelines for ending isolation for COVID-19 patients (2021) (18)
- Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System (2016) (18)
- Structural and biological constraints on diversity of regions immediately upstream of cleavage sites in calicivirus precursor proteins. (2009) (18)
- Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide (2018) (18)
- Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis (1993) (18)
- Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection. (2016) (18)
- Effect of sizofiran, a polysaccharide, on interferon gamma, antibody production and lymphocyte proliferation specific for hepatitis B virus antigen in patients with chronic hepatitis B. (1991) (18)
- Inhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals (2016) (18)
- Characterization of Self-Assembled Virus-Like Particles of Merkel Cell Polyomavirus (2015) (18)
- Modification of hepatitis C virus 1b RNA polymerase to make a highly active JFH1-type polymerase by mutation of the thumb domain (2009) (18)
- Prolactin Regulatory Element Binding Protein Is Involved in Hepatitis C Virus Replication by Interaction with NS4B (2016) (17)
- Nanoimaging of ssRNA: Genome Architecture of the Hepatitis C Virus Revealed by Atomic Force Microscopy (2011) (17)
- Seroprevalence of trichodysplasia spinulosa-associated polyomavirus in Japan. (2015) (17)
- Seroprevalence of chronic hepatitis B, as determined from dried blood spots, among children and their mothers in central Lao People's Democratic Republic: a multistage, stratified cluster sampling survey. (2015) (17)
- Cellular immune responses of peripheral blood mononuclear cells to HBV antigens during chronic and acute HBV infection. (1992) (17)
- The prevalence of TT virus (TTV) infection and its relationship to hepatitis in children (1999) (17)
- Serological evidence of hepatitis E virus infection in dromedary camels in Ethiopia. (2017) (16)
- A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity (2018) (16)
- Distinct genotype and antigenicity among genogroup II sapoviruses (2009) (16)
- Generation of hepatitis E virus-like particles of two new genotypes G5 and G6 and comparison of antigenic properties with those of known genotypes. (2015) (16)
- Possible widespread presence of hepatitis A virus subgenotype IIIA in Japan: Recent trend of hepatitis A causing acute liver failure (2012) (16)
- Saturation Mutagenesis reveals that GLU54 of Norovirus 3C-like Protease is not Essential for the Proteolytic Activity (2008) (16)
- Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro (2021) (16)
- Seroepidemiological study of hepatitis B virus markers in Japan. (2015) (15)
- Production of infectious ferret hepatitis E virus in a human hepatocarcinoma cell line PLC/PRF/5. (2016) (15)
- Resistance mutations of hepatitis B virus in entecavir‐refractory patients (2017) (15)
- Structural insights into the HBV receptor and bile acid transporter NTCP (2022) (15)
- Cell culture-adaptive mutations in the NS5B gene of hepatitis C virus with delayed replication and reduced cytotoxicity. (2009) (15)
- MicroRNA-27a Modulates HCV Infection in Differentiated Hepatocyte-Like Cells from Adipose Tissue-Derived Mesenchymal Stem Cells (2014) (15)
- Completion of the Entire Hepatitis C Virus Life Cycle in Vero Cells Derived from Monkey Kidney (2016) (15)
- Integrin α3 is involved in non-enveloped hepatitis E virus infection. (2019) (15)
- Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins (2022) (15)
- Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry. (2011) (15)
- Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro (2021) (15)
- [Production of infectious hepatitis C virus in cell culture]. (2005) (15)
- Anti-hepatitis C antibodies in patients with chronic non-A, non-B hepatitis: relation to disease progression and effect of interferon alpha. (1991) (15)
- Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B. (1994) (15)
- Sphingomyelin Is Essential for the Structure and Function of the Double-Membrane Vesicles in Hepatitis C Virus RNA Replication Factories (2020) (15)
- Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide (2018) (15)
- Molecular detection of hepatitis E virus in rivers in the Philippines. (2014) (14)
- Establishment of hepatitis E virus infection‐permissive and ‐non‐permissive human hepatoma PLC/PRF/5 subclones (2015) (14)
- Evaluation of Hepatitis C Virus Core Antigen Assays in Detecting Recombinant Viral Antigens of Various Genotypes (2009) (14)
- COVID-19 genome surveillance at international airport quarantine stations in Japan (2020) (14)
- Chronic Hepatitis E Infection in a Persistently Immunosuppressed Patient Unable to Be Eliminated after Ribavirin Therapy (2016) (14)
- Production of Infectious Chimeric Hepatitis C Virus Genotype 2b Harboring Minimal Regions of JFH-1 (2011) (13)
- A Subclone of HuH-7 with Enhanced Intracellular Hepatitis C Virus Production and Evasion of Virus Related-Cell Cycle Arrest (2012) (13)
- Host factor PRPF31 is involved in cccDNA production in HBV-replicating cells. (2017) (13)
- PML tumor suppressor protein is required for HCV production. (2013) (13)
- Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay (2015) (13)
- Bioluminescence technologies to detect calicivirus protease activity in cell-free system and in infected cells (2011) (13)
- Hepatitis C Virus Nonstructural Protein 5A Inhibits Thapsigargin-Induced Apoptosis (2014) (13)
- Hepatitis C virus-induced innate immune responses in human iPS cell-derived hepatocyte-like cells. (2017) (12)
- An in‐house‐anti‐hepatitis A virus (HAV)‐specific immunoglobulin M capture enzyme‐linked immunosorbent assay: Evaluation and application to an HAV outbreak (2009) (12)
- Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives. (2011) (12)
- Single-domain intrabodies against hepatitis C virus core inhibit viral propagation and core-induced NFκB activation. (2016) (12)
- Biological properties of purified recombinant HCV particles with an epitope-tagged envelope. (2010) (12)
- Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C (2015) (12)
- Small Animal Models of Hepatitis E Virus Infection. (2019) (12)
- The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione (2022) (12)
- Hepatitis C virus NS4B targets lipid droplets through hydrophobic residues in the amphipathic helices[S] (2013) (12)
- Raloxifene inhibits hepatitis C virus infection and replication (2012) (12)
- Dual Agonist of Farnesoid X Receptor and Takeda G Protein‐Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo (2021) (12)
- Structural Basis for Specific Recognition of Substrates by Sapovirus Protease (2012) (11)
- Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines. (2012) (11)
- N‐Terminal PreS1 Sequence Regulates Efficient Infection of Cell‐Culture–Generated Hepatitis B Virus (2020) (11)
- Current status of hepatitis E virus infection at a rhesus monkey farm in China. (2019) (11)
- Annexin A1 negatively regulates viral RNA replication of hepatitis C virus. (2015) (11)
- A class II phosphoinositide 3-kinase plays an indispensable role in hepatitis C virus replication. (2013) (11)
- La protein required for internal ribosome entry site-directed translation is a potential therapeutic target for hepatitis C virus replication. (2010) (11)
- Characterization of anti-idiotypic antibodies mimicking antibody- and receptor-binding sites on hepatitis A virus (2009) (11)
- Hepatitis C virus RNA replication in human stellate cells regulates gene expression of extracellular matrix-related molecules. (2011) (11)
- Different mechanisms of hepatitis C virus RNA polymerase activation by cyclophilin A and B in vitro. (2012) (11)
- Development of recombinant hepatitis C virus with NS5A from strains of genotypes 1 and 2. (2011) (10)
- Evaluation of in vitro screening and diagnostic kits for hepatitis B virus infection. (2019) (10)
- Development of an Infectious HCV Cell Culture System (2006) (10)
- Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly. (2019) (10)
- Retrotransposon elements among initial sites of hepatitis B virus integration into human genome in the HepG2-NTCP cell infection model. (2019) (10)
- Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus (2020) (10)
- SARS-CoV-2 Screening Test for Japanese Returnees From Wuhan, China, January 2020 (2020) (10)
- Evaluation of in vitro screening and diagnostic kits for hepatitis C virus infection. (2018) (10)
- HCV genotype 1b chimeric replicon with NS5B of JFH-1 exhibited resistance to cyclosporine A (2009) (10)
- Surfeit 4 Contributes to the Replication of Hepatitis C Virus Using Double-Membrane Vesicles (2019) (10)
- Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People’s Democratic Republic (2019) (9)
- Self‐assembly of sapovirus recombinant virus‐like particles from polyprotein in mammalian cells (2009) (9)
- Inhibition Mechanisms of Hepatitis C Virus Infection by Caffeic Acid and Tannic Acid. (2019) (9)
- Characterization of infectious hepatitis C virus from liver-derived cell lines. (2008) (9)
- Pilot study of ribavirin and interferon-beta for chronic hepatitis B. (1993) (9)
- A retrospective study on imported hepatitis E in Japan. (2012) (9)
- ULBP1 is induced by hepatitis C virus infection and is the target of the NK cell‐mediated innate immune response in human hepatocytes (2018) (9)
- Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems. (2019) (9)
- Novel Permissive Cell Lines for Complete Propagation of Hepatitis C Virus (2014) (9)
- Cell Culture Systems of HCV Using JFH-1 and Other Strains. (2019) (9)
- Comparative site‐directed mutagenesis in the catalytic amino acid triad in calicivirus proteases (2011) (9)
- Detection of Multiple Human Sapoviruses from Imported Frozen Individual Clams (2013) (9)
- Clinical Features and Transmission Pattern of Hepatitis A: An Experience from a Hepatitis A Outbreak Caused by Two Cocirculating Genotypes in Sri Lanka. (2016) (9)
- IL-1β/ATF3-mediated induction of Ski2 expression enhances hepatitis B virus x mRNA degradation. (2018) (9)
- Rethinking antiviral effects for COVID-19 in clinical studies: early initiation is key to successful treatment (2020) (9)
- Comparisons of peripheral blood and hepatic lymphocyte subpopulations and interferon production in chronic viral hepatitis. (1990) (9)
- Identification of hepatitis C virus genotype 2a replicon variants with reduced susceptibility to ribavirin. (2010) (9)
- In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. (1990) (8)
- Comparative characterization of flavivirus production in two cell lines: Human hepatoma-derived Huh7.5.1-8 and African green monkey kidney-derived Vero (2020) (8)
- Genetic and physicochemical analyses of a novel ferret hepatitis E virus, and clinical signs of infection after birth. (2017) (8)
- Vitamin D derivatives inhibit hepatitis C virus production through the suppression of apolipoprotein (2018) (8)
- Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core Protein (2020) (8)
- Activation of protein kinase R by hepatitis C virus RNA-dependent RNA polymerase. (2019) (8)
- Development of a Transcription-Reverse Transcription Concerted Reaction Method for Specific Detection of Human Enterovirus 71 from Clinical Specimens (2012) (8)
- Corrigendum to: Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication [J Hepatol. 2010 Nov;53(5):797–804] (2011) (8)
- Effects of transforming growth factor‐β1 against the inhibitory action of interferon on DNA synthesis and viral replication in hepatitis B virus DNA‐transfected cell (1992) (7)
- Hepatitis B virus prevents excessive viral production via reduction of cell death-inducing DFF45-like effectors. (2017) (7)
- Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1 (2020) (7)
- HCV research and anti-HCV drug discovery: toward the next generation. (2007) (7)
- Single Strain Isolation Method for Cell Culture-Adapted Hepatitis C Virus by End-Point Dilution and Infection (2014) (7)
- Erratum: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (Nature Medicine (2005) 11 (791-796)) (2005) (7)
- Establishment of a novel hepatitis B virus culture system using immortalized human hepatocytes (2020) (7)
- Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression (2015) (7)
- New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication (2013) (7)
- Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide. (2018) (7)
- Rab13 Is Involved in the Entry Step of Hepatitis C Virus Infection. (2016) (7)
- Suppression of hepatitis C virus replication by cyclin-dependent kinase inhibitors. (2014) (7)
- Development of a Particle Agglutination Method with Soluble Virus Receptor for Identification of Poliovirus (2010) (6)
- Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay (2019) (6)
- Baculovirus Mediated Production of Infectious Hepatitis C Virus in Human Hepatoma Cells Stably Expressing T7 RNA Polymerase (2008) (6)
- Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model (2021) (6)
- Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments (2017) (6)
- Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production (2016) (6)
- Anti‐ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C (2011) (6)
- Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhibitor (2019) (6)
- Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus (2016) (6)
- Acute hepatitis B of genotype H resulting in persistent infection. (2014) (6)
- Gamma-interferon production in response to hepatitis B core protein and its synthetic peptides in patients with chronic hepatitis B virus infection. (1990) (6)
- Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigen (2020) (6)
- miR-27b-mediated suppression of aquaporin-11 expression in hepatocytes reduces HCV genomic RNA levels but not viral titers (2019) (6)
- Generation of a recombinant reporter hepatitis C virus useful for the analyses of virus entry, intra-cellular replication and virion production. (2012) (5)
- Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase AID (2013) (5)
- Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial (2021) (5)
- Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-κB-Nuclear Translocation (2015) (5)
- Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virus (1995) (5)
- [Hepatitis C virus vaccine]. (2008) (5)
- Establishment of a human hepatocellular cell line capable of maintaining long-term replication of hepatitis B virus (2017) (5)
- Human-rat chimeric anti-occludin monoclonal antibodies inhibit hepatitis C virus infection. (2019) (4)
- Studies on virus kinetics using infectious fluorescence‐tagged hepatitis C virus cell culture (2011) (4)
- NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization (2021) (4)
- [Defective short variants of S region in chronic HBV carriers]. (1993) (4)
- Screening siRNAs against host glycosylation pathways to develop novel antiviral agents against hepatitis B virus (2020) (4)
- O.174 Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus (2006) (4)
- Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus. (2021) (4)
- Prevalence of equine hepacivirus infection in Mongolia. (2020) (4)
- Detection of Subgenotype IA and IIIA Hepatitis A Viruses in Rivers Flowing through Metro Manila, the Philippines. (2019) (4)
- Determination of Ferret Enteric Coronavirus Genome in Laboratory Ferrets (2017) (4)
- Thermostable hepatitis C virus JFH1-derived variant isolated by adaptation to Huh7.5.1 cells. (2018) (4)
- Hepatitis C Virus-Induced Degradation of Cell Death-Inducing DFFA-Like Effector B Leads to Hepatic Lipid Dysregulation (2016) (4)
- Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers. (2013) (4)
- Genotype 2 a Hepatitis C Virus Subgenomic Replicon Can Replicate in HepG 2 and IMY-N 9 cells (2004) (4)
- Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma (2020) (4)
- The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses (2020) (4)
- No Evidence of Rat Hepatitis E Virus Excretion in Urine Samples of Rats. (2017) (4)
- Detergent-induced activation of the hepatitis C virus genotype 1b RNA polymerase. (2012) (4)
- Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling (2015) (3)
- Development of hepatoma-derived, bidirectional oval-like cells as a model to study host interactions with hepatitis C virus during differentiation. (2017) (3)
- Isolation and characterization of hepatitis C virus resistant to a novel phenanthridinone derivative (2015) (3)
- Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V Mutations (2021) (3)
- Epidemiological assessment of interventions to eliminate mother‐to‐child transmission of hepatitis B virus in japan (2020) (3)
- Development of hepatoma-derived, bidirectional oval-like cells as a model to study host interactions with hepatitis C virus during differentiation (2017) (3)
- Corrigendum to: Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship (2020) (3)
- Characterization of human bocavirus-like particles generated by recombinant baculoviruses. (2014) (3)
- 10 CYCLOPHILIN INHIBITORS POTENTIATE INTERFERON SIGNALING THROUGH DIMINISHED PKR PHOSPHORYLATION IN HCV-INFECTED CELLS (2013) (3)
- Immune response of peripheral blood mononuclear cells to antigenic determinants within hepatitis B core antigen in HB virus-infected man. (2008) (3)
- Effect of recombinant human transforming growth factor β1 on immune responses in patients with chronic hepatitis B (2008) (3)
- Hepatitis C Virus-Induced ROS/JNK Signaling Pathway Activates the E3 Ubiquitin Ligase Itch to Promote the Release of HCV Particles via Polyubiquitylation of VPS4A (2022) (3)
- Cytotoxic T lymphocyte activity to hepatitis B virus DNA-transfected HepG2 cells in patients with chronic hepatitis B (1993) (3)
- Effect of recombinant human transforming growth factor beta 1 on immune responses in patients with chronic hepatitis B. (1993) (3)
- CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection (2014) (2)
- The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro (2022) (2)
- Hepatitis B virus prevents excessive viral production via reduction of cell death-inducing DFF 45-like effectors (2017) (2)
- Virus-like particles of porcine bocavirus generated by recombinant baculoviruses can be applied to sero-epidemic studies. (2016) (2)
- Structural Analysis of Long Single-Stranded RNA Molecules with Atomic Force Microscopy Imaging (2017) (2)
- Caffeic acid , a coffee-related organic acid , inhibits the propagation of hepatitis C virus (2014) (2)
- Hepatitis C Virus II (2016) (2)
- National seroepidemiological study of COVID‐19 after the initial rollout of vaccines: Before and at the peak of the Omicron‐dominant period in Japan (2023) (2)
- MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core Promoter (2021) (2)
- Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy (2017) (2)
- Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/ Ribavirin Therapy in Chronic Hepatitis C (2015) (2)
- Induction of neutralizing antibodies against hepatitis C virus by a subviral particle-based DNA vaccine. (2022) (2)
- Occludin‐binding single‐chain variable fragment and antigen‐binding fragment antibodies prevent hepatitis C virus infection (2020) (2)
- Differences in hepatitis C virus core protein processing among genotypes 1 and 2. (2004) (2)
- Will there be an HCV meeting in 2020? Summary of the 17th international meeting on hepatitis C virus and related viruses. (2011) (2)
- Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers (2021) (2)
- The kinesin KIF4 mediates HBV/HDV entry through regulation of surface NTCP localization and can be targeted by RXR agonists in vitro (2021) (2)
- A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species-specificity (2018) (2)
- Retinoids and rexinoids inhibit hepatitis C virus independently of retinoid receptor signaling. (2014) (2)
- Establishment of infectious genotype 4 cell culture-derived hepatitis C virus. (2019) (2)
- 665 CULTURE OF HEPATITIS C VIRUS (HCV) IN PRIMARY HUMAN ADULT HEPATOCYTES: A PHYSIOLOGICAL MODEL FOR THE PRODUCTION OF AUTHENTIC INFECTIOUS PARTICLES (2010) (2)
- Antiviral Effects of the Anti-Occludin Monoclonal Antibody on Persistent Hepatitis C Virus Infection in a Human Liver Chimeric Mouse Model (2021) (2)
- Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virus. (2021) (2)
- Ledipasvir and Sofosbuvir for Acute Hepatitis C Virus Monoinfection Associated with a High Risk of Acute Liver Failure (2019) (2)
- T cell lines reactive with hepatitis B core and E antigens in patients with chronic hepatitis B. (1991) (1)
- Evaluation of antiviral effects of novel NS5A inhibitors in hepatitis C virus cell culture system with full‐genome infectious clones (2018) (1)
- Establishment of Replication-Competent HCV Strain with Minimum Modifications. (2018) (1)
- encapsidation and particle stabilization (2013) (1)
- Required concentration index quantifies effective drug combinations against hepatitis C virus infection (2020) (1)
- Novel stable HBV producing cell line systems for expression and screening antiviral inhibitor of hepatitis B virus in human hepatoma cell line. (2018) (1)
- Corrigendum: Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression (2015) (1)
- Correction: New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication (2013) (1)
- Proactive Engagement of the Expert Meeting in Managing the Early Phase of the COVID-19 Epidemic, Japan, February–June 2020 (2021) (1)
- P-45 Development and immune response to HCV-core DNA vaccine constructs (1995) (1)
- MafF is an anti-viral host factor that suppresses transcription from Hepatitis B Virus and Epstein Barr Virus promoters (2020) (1)
- Pol I-transcribed hepatitis C virus genome RNA replicates, produces an infectious virus and leads to severe hepatic steatosis in transgenic mice. (2015) (1)
- Annexin A 1 Negatively Regulates Viral RNA Replication of Hepatitis C Virus (2015) (1)
- Evaluation of the use of various rat strains for immunogenic potency tests of Sabin-derived inactivated polio vaccines. (2018) (1)
- [The prevalence of TTV infection and the route of TTV transmission in hemodialysis patients--compared with HCV infection]. (1999) (1)
- Call for papers for the renewed Microbiology and Immunology (2008) (1)
- Hepatitis C virus inhibitor synergism suggests multistep interactions between heat-shock protein 90 and hepatitis C virus replication. (2016) (1)
- Inhibition of hepatitis C virus antigen expression by antisense oligonucleotides directed against 5$prime; noncoding region ribosomal binding sites (1993) (1)
- Neutralization assays for echovirus 18 isolates in 2006. (2007) (1)
- Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells (2021) (1)
- A novel virus culture system for hepatitis C virus (2006) (1)
- Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional Cure (2021) (1)
- Hepatitis B Virus Genotype-Dependent Vulnerability of Infected Cells to Immune Reaction in the Early Phase of Infection (2019) (1)
- Anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) potency of Mefloquine as an entry inhibitor in vitro (2020) (1)
- Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid (2022) (1)
- Identification of Anti-COVID-19 Agents, Cepharanthine and Nelfinavir, and Their Potential Usage for Combination Treatment (2020) (1)
- HCV Culture System and Antiviral Development (2008) (0)
- How do we fight against novel coronaviruses : Japan's strategy with the members of the Council of Experts (2020) (0)
- NSD degrades HBV X-mRNA at the SKIV2L/RNA exosome complex RNA exosome complex regulates stability of Hepatitis B Virus’s X-mRNA transcript in a Non-Stop mediated (NSD) RNA quality control mechanism. (2016) (0)
- Creation of a mouse monoclonal antibody against HCV-E1 protein based on wheat cell-free technology. (2016) (0)
- A confirmation of sapovirus re-infection gastroenteritis cases with different genogroups and genetic shifts in the evolving sapovirus genotypes, 2002-2011 (2012) (0)
- Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide (2018) (0)
- Crystal structure of P domain Q389N mutant from Norovirus Funabashi258 stain in the complex with Lewis-b (2012) (0)
- Structural insights into the HBV receptor and bile acid transporter NTCP (2022) (0)
- Identification and functional analysis of novel E3 ligases interacting with HCV NS4B. (2016) (0)
- O.191 Production of infectious hepatitis C virus in cultured cells (2006) (0)
- Crystal structure of P domain from Norovirus Funabashi258 stain in the complex with A-antigen (2012) (0)
- Patient-derived monoclonal antibody neutralizes HCV infection in vitro and vivo without generating escape mutants (2022) (0)
- Development and Use of a Kinetical and Real-Time Monitoring System to Analyze the Replication of Hepatitis C Virus (2022) (0)
- Expression and immune response to hepatitis C virus DNA vaccine constructs (1995) (0)
- Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus. (2023) (0)
- Maturation and biological importance of hepatitic C virus core protein (1995) (0)
- Notice of triplicate publication. (1990) (0)
- Norovirus Classification, Where are We Headed? (2011) (0)
- [Hepatitis virus culture and anti-viral development]. (2015) (0)
- Specific inhibition of hepatitis C virus core antigen production by antisene RNA constructions (1995) (0)
- A case of acute liver failure with echovirus infection diagnosed by a multi-virus real-time PCR system (2021) (0)
- High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon (2018) (0)
- Prediction of elimination of intrahepatic cccDNA in hepatitis B virus-infected patients by a combination of noninvasive viral markers (2022) (0)
- Crystal structure of P domain from Norovirus Funabashi258 stain in the complex with Lewis-a (2012) (0)
- Novel Neplanocin A Derivatives as Selective Inhibitors of Hepatitis B Virus with a Unique Mechanism of Action (2022) (0)
- Novel HCV cell culture system using a genotype 2 strain with minimum modifications (2017) (0)
- Cytotoxic T lymphocyte activity and HB virus mutant in chronic HB virus carriers (1993) (0)
- Cooperation Between Japan’s NIID and China CDC in Japan’s COVID-19 Response (2020) (0)
- Parallel Session Epidemiology VI QUANTIFYING ANTIVIRAL ACTIVITY OPTIMIZES DRUG COMBINATIONS AGAINST HEPATITIS C VIRUS INFECTION (2018) (0)
- Reduced Resistance of SARS-CoV-2 Variants Toward Affinity-Matured Serological Immunity (2021) (0)
- System for the production of infectious hepatitis C (2006) (0)
- Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells (2021) (0)
- Required concentration index quantifies effective drug combinations against hepatitis C virus infection (2021) (0)
- Hepatitis C Virus Infection Sensitizes Human Hepatocytes to TRAIL-Induced Apoptosis in a Caspase 9-Dependent Manner 1 (2008) (0)
- [Hepatitis C virus culture and its application]. (2011) (0)
- Independent evolution of multi-dominant viral genome species observed in a hepatitis C virus carrier (2022) (0)
- Particle agglutination method for poliovirus identification. (2011) (0)
- Corrigendum to: “Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia” [J Hepatol 2013;59:1073–1080] (2014) (0)
- Inoculation of Plasmids Encoding Japanese Encephalitis Virus PrM-E Proteins with Colloidal Gold Elicits a Protective Immune Response in BALB/c Mice (2003) (0)
- 57: Pivotal role of the IKK-related kinase IKK epsilon to modulate IL29 or type I IFN induction during hepatitis C virus infection (2013) (0)
- Erratum to: A confirmation of sapovirus re-infection gastroenteritis cases with different genogroups and genetic shifts in the evolving sapovirus genotypes, 2002-2011 (2013) (0)
- Genome-wide CRISPR screen for HSV-1 host factors reveals PAPSS1 contributes to heparan sulfate synthesis (2022) (0)
- Title: Novel Cell Culture-Adapted Genotype 2a Hepatitis C Virus Infectious Clone 1 2 (2012) (0)
- [Critical roles of lipids in the HCV life cycle]. (2011) (0)
- Identification of microRNA associated with the elimination of hepatitis C virus genotype 1b by direct‐acting antiviral therapies (2020) (0)
- SEB genotyping: SmartAmp-Eprimer binary code genotyping for complex, highly variable targets applied to HBV (2022) (0)
- Development of an HCV Cell Culture System (2012) (0)
- Absence of viral interference and different susceptibility to interferon between Hepatitis B and C virus in human hepatocyte chimeric mice (2010) (0)
- Author response: Revisiting the guidelines for ending isolation for COVID-19 patients (2021) (0)
- XVIII. A Scientific Expert Advisory Board for the Infectious Disease Criisis (2020) (0)
- Antipoliovirus Activity Target of Enviroxime-Like Compounds for Phosphatidylinositol 4-Kinase III Beta Is a (2013) (0)
- Cell Culture Systems for Propagation of HCV (2016) (0)
- Caspase 9-Dependent Manner Hepatocytes to TRAIL-Induced Apoptosis in a Hepatitis C Virus Infection Sensitizes Human (2011) (0)
- (AID) Activation-induced Cytidine Deaminase Infection via a Cytidine Deaminase Trigger Restriction of Hepatitis B Virus ! Interleukin-1 and Tumor Necrosis Factor- Microbiology: (2014) (0)
- 589 HEPATITIS C VIRUS REPLICATION SENSITIZES HUMAN HEPATOMA CELLS TO TRAIL-INDUCED APOPTOSIS (2008) (0)
- Characterization of Structural Elements in the HCV Genome using Atomic Force Microscopy (2019) (0)
- Erratum to: A confirmation of sapovirus re-infection gastroenteritis cases with different genogroups and genetic shifts in the evolving sapovirus genotypes, 2002-2011 (2013) (0)
- Identification and characterization of human monoclonal anti-E2 antibodies cloned from chronic hepatitis C patient (2016) (0)
- A single mutation in the E2 glycoprotein of hepatitis C virus broadens the claudin specificity for its infection (2022) (0)
- Detection of Multiple Human Sapoviruses from Imported Frozen Individual Clams (2013) (0)
- [Comparison of the HBV-DNA sequences from a chronic hepatitis B patient and her children in cases of vertical transmission]. (1995) (0)
- Activity of antibodies to hepatitis C virus of patients with chronic non-A, non-B hepatitis decreases during interferon α therapy (1991) (0)
- The Reference Panel of Japan for Evaluation of (2012) (0)
- Reply to “Poliovirus-Neutralization Test with Poliovirus Pseudovirus To Measure Neutralizing Antibody in Humans” (2012) (0)
- Viral and Immunological Characteristics of COVID-19 Vaccine Breakthrough Infections (2021) (0)
- Characterization and modification of anti-occludin monoclonal antibodies that inhibit HCV infection (2017) (0)
- 2) Li TC, Yoshizaki S, Ami Y, Suzaki Y, Yasuda SP, (2013) (0)
- Two strategies underlying the trade-off of hepatitis C virus proliferation: stay-at-home or leaving-home? (2019) (0)
- 641 Efficient replication of hepatitis C virus genotype 2A subgenomic replicon isolated from fulminant hepatitis patients (2003) (0)
- Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins (2022) (0)
- In vitro production of antimitochondrial antibody by peripheral blood mononuclear cells in patients with primary biliary cirrhosis. (1991) (0)
- Development of a Particle Agglutination Method with Soluble Virus Receptor for Identification of Poliovirus (cid:1) (2010) (0)
- N6-methyladenosine Modification of Hepatitis B Virus RNA in the Coding Region of HBx (2023) (0)
- Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication (2017) (0)
- Involvement of PUF60 in Transcriptional and Post-transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression (2017) (0)
- About anti-HCV activity mechanism of Guanfacine, a sympatholytic drug. (2017) (0)
- NOTES Nonhepatic Cell Lines HeLa and 293 Support Efficient Replication of the Hepatitis C Virus Genotype 2a Subgenomic Replicon (2004) (0)
- miR-27b-mediated suppression of aquaporin-11 expression in hepatocytes reduces HCV genomic RNA levels but not viral titers (2019) (0)
- Development of large-area amorphous silicon solar cells (1985) (0)
- A Nanoimaging Approach for Identification of the Secondary Structural Domains in Long ssRNA Molecules (2018) (0)
- Structural basis for the RNA-dependent assembly pathway of hepatitis E virion-sized particles (2010) (0)
- Vaccines against hepatitis B and C virus (1995) (0)
- Specific inhibition of hepatitis C virus gene expression by antisense oligonucleotides in a tightly regulated cell culture system (1995) (0)
- Subject Index, Vol. 44, 1989 (1989) (0)
- Correction to: Required concentration index quantifies effective drug combinations against hepatitis C virus infection (2021) (0)
- Hepatitis C virus induced degradation of cell death-inducing DFFA-like effector B 1 leads to hepatic lipid dysregulation 2 3 (2016) (0)
- BPB Reports (2021) (0)
- A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19 (2023) (0)
- Inhibition par oligonucleotides antisens du virus de l'hepatite c (1995) (0)
- Correction to: Required concentration index quantifies effective drug combinations against hepatitis C virus infection (2021) (0)
- Comparative characterization of human hepatoma-derived Huh7.5.1-8 cells and African green monkey kidney-derived Vero cells in Japanese encephalitis virus production (2017) (0)
- Modified genomic rna of the human hepatitis C virus with autonomous replication competence (2005) (0)
- Nucleic acid construction containing the hepatitis c (hcv) virus of the nucleic acid of genomic origin of genotipo 2a and cell that has the nucleic acid construction transferred to the inside. (2003) (0)
- Human sapovirus classification based on complete capsid nucleotide sequences (2011) (0)
- Will Vitamin D Supplementation Have a Role in the Treatment of Patients with Chronic Hepatitis C (2012) (0)
- Hepatitis C Virus Replikation sensitiviert humane Hepatomazellen auf TRAIL-induzierte Apoptose (2008) (0)
- Compoundsof Minor Enviroxime-Like Oxysterol-Binding Protein Family I Is the (2014) (0)
- 449 Hepatitis C virus structural proteins and activation of Toll-like receptors 2 and 4 (2006) (0)
- CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection (2014) (0)
- Expression of a functional intrabody against hepatitis C virus core protein in Escherichia coli and silkworm pupae. (2018) (0)
- O.192 Scavenger receptor class B type I is a co-receptor for infection with cell culture-derived hepatitis C virus (2006) (0)
- Tumor vaccination against hepatoma: How does it work? (1994) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Takaji Wakita?
Takaji Wakita is affiliated with the following schools: